1,569
Views
3
CrossRef citations to date
0
Altmetric
Hepatology

Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluations

Pages 727-729 | Received 12 Apr 2021, Accepted 10 May 2021, Published online: 31 May 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.